FIELD: medicine.
SUBSTANCE: group of inventions relates to the field of medicine, namely, a prolonged-release tablet for the prevention and/or treatment of transthyretin-associated amyloidosis, containing micronized tolcapone, a cellulose polymer selected from the group consisting of cellulose esters and cellulose esters, and microcrystalline cellulose, and also relates to a method for the prevention and/or treatment of transtyretin-associated amyloidosis, as well as to the use of micronized tolcapone, as well as to a pharmaceutical composition in the form of a tablet and the method for manufacturing the tablet.
EFFECT: group of inventions provides for the production of a prolonged-release tablet containing tolcapone.
15 cl, 1 dwg, 5 ex, 8 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS OF STABLE TIACUMICINES | 2008 |
|
RU2484829C2 |
| SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION CONTAINING RIVASTIGMINE | 2016 |
|
RU2727721C2 |
| NEW TRANSTHYRETIN-RELATED AMYLOIDOSIS THERAPY | 2012 |
|
RU2623062C2 |
| NEW THERAPY OF TRANSTHYRETIN-ASSOCIATED AMYLOIDOSIS | 2012 |
|
RU2747536C2 |
| COMBINED COMPOSITION CONTAINING METFORMIN OF SUSTAINED RELEASE AND INHIBITOR HMG-CoA-REDUCTASE OF IMMEDIATE RELEASE | 2014 |
|
RU2651460C2 |
| PHARMACEUTICAL COMPOSITION OF METFORMIN WITH PROLONGED RELEASE AND METHOD OF ITS OBTAINING | 2006 |
|
RU2433821C2 |
| COMPOSITIONS OF ORALLY DISPERSIBLE TABLETS CONTAINING COMBINATIONS OF HIGH- AND LOW-DOSE THERAPEUTIC AGENTS | 2010 |
|
RU2554740C2 |
| PER ORALLY DECOMPOSING TABLET COMPOSITIONS, CONTAINING COMBINATIONS OF NON-OPIATE ANALGESICS | 2010 |
|
RU2567032C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ROSUVASTATIN CALCIUM SALT (VERSIONS) | 2015 |
|
RU2606592C1 |
| PHARMACEUTICAL COMPOSITIONS, CONTAINING IMATINIB AND RELEASE MODERATOR | 2006 |
|
RU2404775C2 |
